SnagRx vs Gala: Compounded GLP-1 pricing, shipping, and care
Quick verdict: For the lowest advertised annual compounded semaglutide price and named pharmacy partners, SnagRx leads; Gala emphasizes bundled provider check-ins and a promotional discount but does not expose a base price in readable text.
See SnagRx pricing and details
This comparison looks at SnagRx vs Gala across price transparency, clinician and pharmacy disclosure, shipping speed, bundled care, and regulatory notes. Both are direct-pay telehealth platforms offering compounded semaglutide and tirzepatide, no insurance required, and claim a single flat price at every dose. Below we compare the most distinctive differences supported by the sources.
SnagRx vs Gala: price transparency and structure
SnagRx posts explicit pricing: compounded semaglutide from $69/month and tirzepatide from $119/month on a 12-month plan; month-to-month rates are $99 and $149. The $69 and $119 figures are the 12-month plan rates and SnagRx states the rate is locked flat at every dose and at renewal. Gala promotes a flat all-inclusive price and a $220 promotion but the base monthly price was not visible in the captured page text; the page also advertises compounded semaglutide from $249/mo in a headline. Both claim no monthly membership and cancel anytime policies.
Direct comparison
| Criteria | SnagRx | Gala |
|---|---|---|
| Visible starting price | $69/mo semaglutide on 12-month plan; $99 mo month-to-month | Headline cites $249/mo; captured page text did not expose a readable base price |
| Price locked at dose | Rate locked flat at every dose and renewal | Claims one flat price at every dose |
| Clinician disclosure | Medical care via OpenLoop Health clinician network; clinician review typically within 5 hours | Provider visit and prescription included; ongoing provider check-ins included |
| Pharmacy disclosure | Names its US 503A partner pharmacies | Compounded medications offered; specific pharmacies not named in captured text |
| Shipping speed | Next-day UPS/FedEx; arrives in 1-2 days stated | Free 2-day shipping claimed |
| Regulatory note | Compounded medications are not FDA-approved; produced in FDA-regulated facilities | Compounded medications are not FDA-approved |
Clinician involvement and ongoing care
SnagRx uses a named clinician network, OpenLoop Health, and states clinicians will review the intake typically within five hours and always within 24; an OpenLoop clinician meets with individuals after checkout to determine eligibility and prescribe. Gala includes provider visit, prescription, and provider check-ins and dose monitoring as part of the service. Gala emphasizes ongoing check-ins in its bullets; SnagRx highlights clinician review speed and a clinician network by name.
Check Gala eligibility and care details
Pharmacy naming, compounded status, and regulatory qualifiers
SnagRx names its four US 503A partner pharmacies and states compounding is used; it adds the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. SnagRx also states its compounded medications are produced in FDA-regulated facilities but are not FDA-approved finished products. Gala likewise notes that compounded medications are not FDA-approved. Gala does not show named pharmacy partners in the captured text.
Shipping, timing, and refunds
SnagRx claims next-day UPS or FedEx shipping in temperature-controlled packaging, with a full refund if the prescription is declined. Gala claims free two-day shipping. Both state no insurance is required, no monthly membership, and cancel anytime terms in their marketing text.
View SnagRx shipping and refund terms
Marketing claims and transparency differences
SnagRx emphasizes bottom-of-market annual pricing, the price lock at every dose, named pharmacies, and a stated clinician network; it also discloses that the advertised low rates require a 12-month commitment and that month-to-month rates are higher. Gala emphasizes a promotional discount (claimed $220 off) and bundled provider check-ins but the captured page did not show a clear, readable base monthly price. Testimonials and specific weight-loss figures on Gala’s page are marked as marketing content in the capture.
See Gala pricing options and promo
Conclusion: SnagRx vs Gala and final recommendation
SnagRx vs Gala comes down to pricing transparency and disclosed partnerships versus bundled provider check-ins and a promotional offer. SnagRx provides explicit 12-month plan prices ($69/mo semaglutide, $119/mo tirzepatide), names its US 503A pharmacies and clinician network, and promises next-day shipping and a clinician review timeline. Gala promises a single flat price at every dose, provider check-ins, and free two-day shipping but the base price was not exposed in the captured text and the page shows a promotional discount.
Choose SnagRx if you want clearly posted 12-month pricing, a named clinician network and named 503A partner pharmacies, and next-day shipping with a stated clinician review timeline. Choose Gala if you prioritize bundled provider check-ins and the promotional offer but confirm the base price, renewal terms, and state availability before enrolling.